Results 11 to 20 of about 82,833 (333)

Progressive multifocal leukoencephalopathy [PDF]

open access: yesRomanian Journal of Neurology, 2008
Progressive multifocal leukoencephalopathy is a demyelinating disease of the central nervous system caused by the reactivation of latent JC virus.
Rosca Elena Cecilia   +4 more
doaj   +9 more sources

Progressive Multifocal Leukoencephalopathy [version 1; referees: 2 approved] [PDF]

open access: yesF1000Research, 2015
Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disease with significant morbidity and mortality and no effective, targeted therapies.
Laura Adang, Joseph Berger
doaj   +3 more sources

Progressive multifocal leukoencephalopathy [PDF]

open access: bronzeCurrent Neurology and Neuroscience Reports, 2000
Progressive multifocal leukoencephalopathy (PML) was a rare disease until the advent of the HIV/AIDS pandemic. Recent interest in the disorder has been spurred by its appearance in patients treated with the monoclonal antibodies natalizumab and rituximab.
Joseph R. Berger
openalex   +11 more sources

Progressive Multifocal Leukoencephalopathy in an AIDS Patient

open access: yesJournal of the Formosan Medical Association, 2007
Progressive multifocal leukoencephalopathy (PML) is a demyelinating brain disease caused by Jamestown Canyon virus (JCV). This disease is an important cause of morbidity and mortality in acquired immunodeficiency syndrome (AIDS) patients.
Ming-Hsing Lee   +2 more
doaj   +4 more sources

”Shrimp sign” in progressive multifocal leukoencephalopathy [PDF]

open access: yesAnnals of Indian Academy of Neurology
Ayush Agarwal   +3 more
doaj   +2 more sources

Progressive Multifocal Leukoencephalopathy [PDF]

open access: yesMayo Clinic Proceedings, 2018
Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection that occurs in patients whose immune system is compromised either because of an underlying illness or an immunosuppressive medication. John Cunningham virus, prevalent in 60% or more of the adult population as a latent or persistent infection, is responsible for the ...
Melissa M. Blessing   +2 more
  +10 more sources

Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors

open access: yesAnnals of Neurology, 2022
Our aim was to assess the real‐world effectiveness of immune checkpoint inhibitors for treatment of patients with progressive multifocal leukoencephalopathy (PML).
Xavier Boumaza   +20 more
semanticscholar   +1 more source

Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions.

open access: yesBrain : a journal of neurology, 2022
Population-based data on the epidemiology of progressive multifocal leukoencephalopathy, its predisposing conditions and mortality rate are lacking, although such data are crucial to raise awareness among clinicians and to lay foundations for future ...
M. Joly   +7 more
semanticscholar   +1 more source

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy

open access: yesJournal of Neurology, 2022
Progressive multifocal leukoencephalopathy (PML) is an opportunistic viral disease of the brain—caused by human polyomavirus 2. It affects patients whose immune system is compromised by a corresponding underlying disease or by drugs.
N. Möhn   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy